Adjuvant Gemcitabine and Nab-Paclitaxel Misses the Target in Pancreas Adenocarcinoma: Or Did an Effective Therapy Fall to the Definition of Recurrence?
Gulam A ManjiPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)